Popular Trials
CAR T-cell Therapy
Combination Therapies for Multiple Myeloma
Recruiting1 awardPhase 2
Duarte, California
"This trial aims to see how well the treatment is working by evaluating the rate of response and potential cure after 5 years. They will look at whether the treatment leads to minimal residual disease negativity, complete
JoyRise Recovery Powder for Cognitive Impairment
Recruiting0 awards5 criteria
Santa Monica, California
This study assesses the effectiveness of JoyRise Recovery Powder in reducing alcohol aftereffects, cognitive impairment, and anxiousness among participants aged 35-54 who consume alcohol. Participants will be randomly assigned to either the JoyRise group or a placebo group. The study will measure hangover symptoms, cognitive function, and overall well-being through a series of questionnaires and cognitive tests at baseline, 30 minutes after product consumption, and 4 hours later.
Popular Filters
Phase 3 Trials
Monoclonal Antibodies
Belimumab for Interstitial Lung Disease
Recruiting1 awardPhase 3
Los Angeles, California
This trial will investigate whether adding a medication called belimumab to standard therapy can help stabilize or improve lung function and reduce symptoms in participants with connective tissue disease-associated interstitial lung disease (ILD).
Trials With No Placebo
Procedure
Hemodialysis System for Kidney Disease
Recruiting1 award1 criteria
Ontario, California
This trial involves using a device that has been approved by the FDA for use in dialysis treatment. Patients who agree to participate will receive their regular dialysis treatment in a professional healthcare setting.
ART-Pro-1 for Prostate Cancer
Recruiting1 award3 criteria
San Diego, California
This is a multicenter, multinational trial to evaluate advanced MRI techniques for improved detection of clinically significant prostate cancer (csPCa). The study will enroll 500 participants at 5 clinical centers (100 participants per center). The current standard MRI technique for prostate cancer screening is multiparametric MRI (mpMRI), but two drawbacks include need for intravenous (IV) contrast and dependence on radiologist expertise. The investigators expect that the combination of two other techniques, biparametric MRI (bpMRI) and Restriction Spectrum Imaging restriction score (RSIrs), will help non-expert radiologists achieve similar performance to expert radiologists using bpMRI or mpMRI for detection of csPCa, while avoiding the drawbacks that are present when using mpMRI.
Behavioural Intervention
Core Shamanism for Fibromyalgia
Recruiting1 award3 criteria
Irvine, California
This trial aims to see if a shamanism intervention can help patients with fibromyalgia by reducing their pain and other symptoms. The researchers also want to see if this intervention affects the heart rate
Chest X-ray Tomosynthesis Participants for Lung Cancer
Recruiting1 award3 criteria
San Diego, California
The goal of this observational clinical trial is to learn if chest tomosynthesis is a potential alternative to computed tomography for the detection of lung cancer. It will also develop artificial intelligence tools to aid in the diagnosis of lung cancer on chest tomosynthesis images. The main questions it aims to answer are: * What is the accuracy of chest X-ray tomosynthesis in diagnosing lung cancer in a population of individuals undergoing lung cancer screening or evaluation of a suspicious lung nodule? * Can artificial intelligence help us detect lung cancer on chest tomosynthesis images? Researchers will compare chest tomosynthesis images to computed tomography scans for each participant to see how they compare in diagnosing lung cancer. Participants will a chest tomosynthesis scan in addition to their routine clinical computed tomography scan.
Trials Offering Remuneration
CAR T-cell Therapy
NEXI-001 + Decitabine for AML or MDS
Recruiting1 awardPhase 1
Duarte, California
This trial is testing the safety and effectiveness of a new therapy called NEXI-001, which involves modifying a patient's immune cells to attack cancer cells. The trial is specifically for patients with acute
Behavioural Intervention
PRIDE Therapy for Eating Disorders
Recruiting1 awardPhase 1
San Diego, California
This trial aims to see if a new treatment called PRIDE can help sexual minority populations with eating disorders by reducing internalized stigma and improving coping with stress. Participants will go through screening processes, attend therapy
XXB750 s.c 60 mg for Clinical Trials
Recruiting0 awardsPhase 1
Cypress, California
This study was a randomized, participant and investigator-blinded, placebo-controlled, single-ascending dose study, consisting of 9 sequential dose cohorts (1 mg, 3 mg, 10 mg, 30 mg, 60 mg, 120 mg, 240 mg, 450 mg and 600 mg) and a Japanese ethnic sensitivity cohort (240 mg dose)
Behavioural Intervention
Time-Restricted Eating for Alzheimer's Disease
Recruiting1 awardPhase 1
San Diego, California
This trial aims to investigate if fasting for 14 hours at night can help reduce sleep problems, cognitive decline, and disease progression in individuals with Mild Cognitive Impairment (MCI) or early to
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.